The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: ECBio has developed proprietary technology to consistently isolate, expand and cryopreserve a well-characterized population of stromal cells from human umbilical cord tissue (UCX® cells). The technology has recently been optimized in order to become compliant with Advanced Medicine Therapeutic Products. In this work we report the immunosuppressive capacity of UCX® cells for treating induced autoimmune inflammatory arthritis. METHODS: UCX® cells were isolated using a proprietary method (PCT/IB2008/054067) that yields a well-defined number of cells using a precise proportion between tissue digestion enzyme activity units, tissue mass, digestion solution volume and void volume. The procedure includes three recovery steps to avoid non-conformities related to cell recovery. UCX® surface markers were characterized by flow cytometry and UCX® capacity to expand in vitro and to differentiate into adipocyte, chondrocyte and osteoblast-like cells was evaluated. Mixed Lymphocyte Reaction (MLR) assays were performed to evaluate the effect of UCX® cells on T-cell activation and Treg conversion assays were also performed in vitro. Furthermore, UCX® cells were administered in vivo in both a rat acute carrageenan-induced arthritis model and rat chronic adjuvant induced arthritis model for arthritic inflammation. UCX® anti-inflammatory activity was then monitored over time. RESULTS: UCX® cells stained positive for CD44, CD73, CD90 and CD105; and negative for CD14, CD19 CD31, CD34, CD45 and HLA-DR; and were capable to differentiate into adipocyte, chondrocyte and osteoblast-like cells. UCX® cells were shown to repress T-cell activation and promote the expansion of Tregs better than bone marrow mesenchymal stem cells (BM-MSCs). Accordingly, xenogeneic UCX® administration in an acute carrageenan-induced arthritis model showed that human UCX® cells can reduce paw edema in vivo more efficiently than BM-MSCs. Finally, in a chronic adjuvant induced arthritis model, animals treated with intra-articular (i.a.) and intra-peritoneal (i.p.) infusions of UCX® cells showed faster remission of local and systemic arthritic manifestations. CONCLUSION: The results suggest that UCX® cells may be an effective and promising new approach for treating both local and systemic manifestations of inflammatory arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target
Sojka, D. K., Huang, Y., & Fowell, D. J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02813.x · Cited by 393 · cited 11×
“The generation of iTregs is dependent upon the presence of both TGF-β and TGF-β receptor signals.”
BackgroundInfluentialDuarte, J., Carrié, N., Oliveira, V. G., Almeida, C., Agua-Doce, A., Rodrigues, L., Simas, J. P., Mars, L. T., & Graca, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201269 · Cited by 13
Self-citation
Cited by
Santos, J. M., Camões, S. P., Filipe, E., Cipriano, M., Barcia, R. N., Filipe, M., Teixeira, M., Simões, S., Gaspar, M., Mosqueira, D., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0082-5 · Cited by 196
Self-citationMiranda, J. P., Camões, S. P., Gaspar, M. M., Rodrigues, J. S., Carvalheiro, M., Bárcia, R. N., Cruz, P., Cruz, H., Simões, S., & Santos, J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00018 · Cited by 109
Self-citationBárcia, R. N., Santos, J. M., Teixeira, M., Filipe, M., Pereira, A. R. S., Ministro, A., Água-Doce, A., Carvalheiro, M., Gaspar, M. M., Miranda, J. P., et al. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2016.11.008 · Cited by 40
Self-citationMiranda, J. P., Filipe, E., Fernandes, A. S., Almeida, J. M., Martins, J. P., De La Fuente, A., Abal, M., Barcia, R. N., Cruz, P., Cruz, H., et al. (2015) · Cell Transplantation · doi:10.3727/096368913x676231 · Cited by 38
Self-citationMesenchymal Stem Cells for Cutaneous Wound Healing
Camões, S. P., Santos, J. M., Carvalho, F., & Miranda, J. P. (2020) · Learning Materials in Biosciences · doi:10.1007/978-3-030-43939-2_13 · Cited by 6
Self-citation
Metadata
- Authors
- Santos, J. M., Bárcia, R. N., Simões, S. I., Gaspar, M. M., Calado, S., Água-Doce, A., Almeida, S. C., Almeida, J., Filipe, M., Teixeira, M., Martins, J. P., Graça, L., Cruz, M. E., Cruz, P., & Cruz, H.
- Venue
- Journal of Translational Medicine
- Published
- 2013-01-17
- Volume
- 11
- Issue
- 1
- Pages
- 18-18
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2103448559
- Cited by
- 51
- References
- 2
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis. https://app.cochat.ai/papers/10.1186/1479-5876-11-18
- The paper
- Santos, J. M., Bárcia, R. N., Simões, S. I., Gaspar, M. M., Calado, S., Água-Doce, A., Almeida, S. C., Almeida, J., Filipe, M., Teixeira, M., Martins, J. P., Graça, L., Cruz, M. E., Cruz, P., & Cruz, H. (2013). The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-11-18
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.